Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Thompson

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research GroupD M Black, D E Thompson, D C Bauer, et al.
Journal of the American Geriatrics Society|March 25, 2000
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research GroupK E Ensrud, D E Thompson, J A Cauley, et al.
Journal of Aquatic Animal Health|August 13, 2011
Survey of pathogens in hatchery Chinook salmon with different out-migration histories through the Snake and Columbia riversA L Van Gaest, J P Dietrich, D E Thompson, et al.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
The American Journal of Medicine|October 1, 1996
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trialI R Reid, G C Nicholson, R S Weinstein, et al.
Journal of Neural Engineering|July 20, 2017
Neural control of finger movement via intracortical brain-machine interfaceZ T Irwin, K E Schroeder, P P Vu, et al.
JAMA|January 6, 1999
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialS R Cummings, D M Black, D E Thompson, et al.
Neuroscience Letters|November 15, 2017
Region-specific alterations in astrocyte and microglia morphology following exposure to blasts in the mouse hippocampusGloria J DeWalt, Biraaj Mahajan, Andrea R Foster, et al.
Lancet (London, England)|December 7, 1996
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research GroupD M Black, S R Cummings, D B Karpf, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The Journal of Clinical Endocrinology and Metabolism|November 30, 2000
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research GroupD M Black, D E Thompson, D C Bauer, et al.
Journal of the American Geriatrics Society|March 25, 2000
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research GroupK E Ensrud, D E Thompson, J A Cauley, et al.
Journal of Aquatic Animal Health|August 13, 2011
Survey of pathogens in hatchery Chinook salmon with different out-migration histories through the Snake and Columbia riversA L Van Gaest, J P Dietrich, D E Thompson, et al.
Clinical Therapeutics|November 26, 1998
Evidence that increased calcium intake does not prevent early postmenopausal bone lossD J Hosking, P D Ross, D E Thompson, et al.
The American Journal of Medicine|October 1, 1996
Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trialI R Reid, G C Nicholson, R S Weinstein, et al.
Journal of Neural Engineering|July 20, 2017
Neural control of finger movement via intracortical brain-machine interfaceZ T Irwin, K E Schroeder, P P Vu, et al.
JAMA|January 6, 1999
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialS R Cummings, D M Black, D E Thompson, et al.
Neuroscience Letters|November 15, 2017
Region-specific alterations in astrocyte and microglia morphology following exposure to blasts in the mouse hippocampusGloria J DeWalt, Biraaj Mahajan, Andrea R Foster, et al.
Lancet (London, England)|December 7, 1996
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research GroupD M Black, S R Cummings, D B Karpf, et al.
Aging (Milan, Italy)|April 4, 2000
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study GroupT Schnitzer, H G Bone, G Crepaldi, et al.
Pageof 9